BNA Team
Laura Ajram
Laura studied Pharmacology at King’s College London (including a year in industry with GlaxoSmithKline) before completing her PhD at the Institute for Psychiatry, Psychology and Neuroscience on the topic of ‘the Neuropharmacology of Autism Spectrum Disorders’.
In 2021 Laura was awarded the ‘ELRIG Early Career Impact Award’ for making a ‘significant impact in the drug discovery community’, and in 2022, a prestigious Fellowship to the British Pharmacological Society in recognition of her ongoing contribution to the sector.
Laura has worked across NHS, charity, academic and pharmaceutical research settings to develop strategic cross-sector partnerships and accelerate neuroscience drug discovery efforts in mental health, dementia and motor neurone disease.
Laura is currently Chief Executive of the British Neuroscience Association, where she is responsible for delivering the vision, mission and strategy of the BNA and it’s subsidiary company, BNA Events Ltd.
